News

Technology News

Ambry Genetics Launches Clinical Exome Sequencing

Thursday, March 27, 2014 5:01:00 AM PDT | VentureDeal
   Aliso Viejo, CA  --  Ambry Genetics has announced the launch of two new clinical exome sequencing assays.

Called ExomeNext and ExomeNext-Rapid, the assays provide whole exome sequencing in as little as 2-5 week turnaround times.

The company says that its high diagnostic rate is due to an internal database of characterized and disease-causing genes.

Further, it said that 23% of its positive findings are from newly characterized genes that were described within the last two years.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1